Implementing the appropriate laboratory instrumentation to support therapeutic development is crucial to the process of drug discovery. Life science and analytical instrumentation facilitates pharmaceutical R&D throughout these stages. SDi has observed the dynamics of the pharma/bio sector demand for instrumentation to support innovative biologics, small molecule drugs, regenerative pharmaceuticals, and biopharmaceuticals. Most of these drug […]
About Daniel Granderson
This author has not written his bio yet.
But we are proud to say that Daniel Granderson contributed 2 entries already.
Entries by Daniel Granderson
Testing has been at the forefront of public health efforts and challenges since the beginning of the pandemic caused by SARS-CoV-2, the virus responsible for COVID-19 disease. By April last year, it became increasingly clear that testing would be crucial to public health and safety. However, global testing capacities substantially lagged behind demand as shortages […]
November 29, 2023 6:34 pm
October 17, 2023 6:31 pm
September 21, 2023 3:24 pm
Your Data and Privacy
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.